Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal …
I Nebie, A Diarra, A Ouedraogo, I Soulama… - Infection and …, 2008 - Am Soc Microbiol
There is longstanding evidence that immunoglobulin G (IgG) has a role in protection against
clinical malaria, and human antibodies of the cytophilic subclasses are thought to be …
clinical malaria, and human antibodies of the cytophilic subclasses are thought to be …
[HTML][HTML] Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in …
…, AZ Ouédraogo, A Diarra, A Gansané, I Soulama… - PLoS …, 2011 - journals.plos.org
Background Intermittent preventive treatment of malaria in children (IPTc) is a promising
new approach to the control of malaria in areas of seasonal malaria transmission but it is not …
new approach to the control of malaria in areas of seasonal malaria transmission but it is not …
[HTML][HTML] Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections
…, K Lanke, A Ouedraogo, I Soulama… - Nature …, 2021 - nature.com
Plasmodium falciparum gametocyte kinetics and infectivity may differ between chronic and
incident infections. In the current study, we assess parasite kinetics and infectivity to …
incident infections. In the current study, we assess parasite kinetics and infectivity to …
[HTML][HTML] Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso
I Soulama, I Nébié, A Ouédraogo, A Gansane, A Diarra… - Malaria journal, 2009 - Springer
Background The clinical presentation of malaria, considered as the result of a complex
interaction between parasite and human genetics, is described to be different between rural and …
interaction between parasite and human genetics, is described to be different between rural and …
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
…, L Belarbi, A Diarra, N Henry, I Soulama… - The Lancet Infectious …, 2020 - thelancet.com
Background PRIMVAC is a VAR2CSA-derived placental malaria vaccine candidate aiming
to prevent serious clinical outcomes of Plasmodium falciparum infection during pregnancy. …
to prevent serious clinical outcomes of Plasmodium falciparum infection during pregnancy. …
[HTML][HTML] Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised …
I Sagara, AH Beavogui, I Zongo, I Soulama… - The Lancet, 2018 - thelancet.com
Background Artemether–lumefantrine and artesunate–amodiaquine are used as first-line
artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine–artesunate and …
artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine–artesunate and …
[HTML][HTML] Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
I Sagara, AH Beavogui, I Zongo, I Soulama… - The Lancet Infectious …, 2016 - thelancet.com
Background Sparse data on the safety of pyronaridine-artesunate after repeated treatment
of malaria episodes restrict its clinical use. We therefore compared the safety of pyronaridine-…
of malaria episodes restrict its clinical use. We therefore compared the safety of pyronaridine-…
Variation in natural exposure to anopheles mosquitoes and its effects on malaria transmission
…, K Lanke, S Zongo, N Sepulveda, I Soulama… - Elife, 2018 - elifesciences.org
10.7554/eLife.32625.001 Variation in biting frequency by Anopheles mosquitoes can
explain some of the heterogeneity in malaria transmission in endemic areas. In this study in …
explain some of the heterogeneity in malaria transmission in endemic areas. In this study in …
[HTML][HTML] A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with …
…, F Bohissou, DP Mawili-Mboumba, F Olewe, I Soulama… - Malaria Journal, 2021 - Springer
Background For uncomplicated Plasmodium falciparum malaria, highly efficacious single-dose
treatments are expected to increase compliance and improve treatment outcomes, and …
treatments are expected to increase compliance and improve treatment outcomes, and …
[HTML][HTML] Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12–24 months-old Burkinabe children
…, AT Konaté, Y Kaboré, A Traoré, C Roma, I Soulama… - PloS one, 2009 - journals.plos.org
Background A Phase Ia trial in European volunteers of the candidate vaccine merozoite
surface protein 3 (MSP3), a Plasmodium falciparum blood stage membrane, showed that it …
surface protein 3 (MSP3), a Plasmodium falciparum blood stage membrane, showed that it …